To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DNPEPTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
483 representative clones for gene DNPEP back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI830094 brain, medulla .a 1 to 631 1 to 639   tiling clone,   639/640
(99 %)
20 diff
(96.9 %id)
TI_57170782   .a 1 to 631 32 to 670       639/671
(95 %)
24 diff
(96.5 %id)
AK301919 testis .a 16 to 1643 1 to 1628   tiling clone,   1628/1628
(100 %)
2 diff
(99.9 %id)
DB462058 testis .a 16 to 503 1 to 488       488/488
(100 %)
2 diff
(99.6 %id)
DC396118 testis .a 16 to 615 1 to 600       600/600
(100 %)
0 diff
(100 %id)
TI_57170285   .a 24 to 645 25 to 649       625/649
(96 %)
8 diff
(98.8 %id)
TI_57175703   .a 28 to 785 54 to 810       757/810
(93 %)
9 diff
(98.9 %id)
BI825729 brain, medulla .a 29 to 645 1 to 620       620/620
(100 %)
3 diff
(99.6 %id)
BI831780 brain, medulla .a 33 to 785 1 to 753       753/753
(100 %)
3 diff
(99.7 %id)
DC398628 testis .a 36 to 602 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
DC399376 testis .a 43 to 590 10 to 559       550/550
(100 %)
2 diff
(99.7 %id)
TI_1948085885   .a 156 to 827 129 to 802   fully sequenced,   675/803
(84 %)
6 diff
(99.3 %id)
CF141283 CNCAP(3)T-225 cell line, Prostate .a 158 to 637 4 to 483       483/483
(100 %)
2 diff
(99.6 %id)
TI_1948086052   .a 158 to 874 137 to 852   fully sequenced,   717/853
(84 %)
7 diff
(99.2 %id)
BG178380 adenocarcinoma, cell line, Prostate .a 161 to 897 1 to 734       734/915
(80 %)
12 diff
(98.7 %id)
BM805777 brain, hippocampus .a 162 to 739 127 to 713       585/1214
(48 %)
16 diff
(98.7 %id)
BM423640 amelanotic melanoma, cell line, skin .a 166 to 1054 1 to 890       890/996
(89 %)
13 diff
(98.7 %id)
BQ430073 large cell carcinoma, lung .a 182 to 1036 13 to 875       863/876
(98 %)
19 diff
(97.9 %id)
BX483768   .a 185 to 871 1 to 685       685/685
(100 %)
3 diff
(99.6 %id)
BQ953949 eye, normal pigmented retinal epithelium .a 218 to 1057 1 to 844       846/908
(93 %)
18 diff
(98.1 %id)
BG762270 melanotic melanoma, high MDR (cell line), skin .a 239 to 1059 1 to 825       825/837
(98 %)
8 diff
(99.1 %id)
BE387293 melanotic melanoma, skin .a 253 to 831 60 to 635       575/636
(90 %)
11 diff
(98.3 %id)
BQ935238 brain, neuroblastoma, cell line .a 265 to 1199 1 to 946       946/949
(99 %)
28 diff
(97.1 %id)
BE895422 melanotic melanoma, skin .a 284 to 970 1 to 688       688/807
(85 %)
14 diff
(98.3 %id)
CA487247   .a 290 to 1186 1 to 899       897/900
(99 %)
8 diff
(99.2 %id)
CV339676 breast .a 291 to 798 517 to 12     Submitted on the opposite strand 506/517
(97 %)
0 diff
(100 %id)
BQ278086 ovary, teratocarcinoma, cell line .a 296 to 974 1 to 681       681/1218
(55 %)
17 diff
(98.7 %id)
BU846025 ovary, teratocarcinoma, cell line .a 296 to 1197 1 to 903       903/903
(100 %)
10 diff
(98.9 %id)
CN356168 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 303 to 873 10 to 580       571/580
(98 %)
6 diff
(99.0 %id)
CR602255 Neuroblastoma Cot 25-normalized .a 303 to 1621 1 to 1319       1319/1319
(100 %)
0 diff
(100 %id)
BX333317 Neuroblastoma Cot 25-normalized .a 303 to 1004 1 to 702   fully sequenced,   702/702
(100 %)
1 diff
(99.9 %id)
BX383220   .a 304 to 700 1 to 397       397/397
(100 %)
11 diff
(97.3 %id)
BG284720 adenocarcinoma, cell line, Prostate .a 313 to 1132 1 to 811       813/1011
(80 %)
24 diff
(97.7 %id)
CA391092 eye, RPE/choroid .a 318 to 847 1 to 530       530/530
(100 %)
0 diff
(100 %id)
R48031 breast .a 318 to 612 1 to 296       296/296
(100 %)
3 diff
(99.0 %id)
BE266840 lung, small cell carcinoma .a 337 to 905 1 to 569       569/569
(100 %)
4 diff
(99.3 %id)
BE890838 melanotic melanoma, skin .a 373 to 1056 1 to 700       700/860
(81 %)
15 diff
(98.3 %id)
BM799116 Ascites, stomach .a 396 to 968 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
DA385321 thalamus .a 398 to 906 2 to 510   capped   509/509
(100 %)
1 diff
(99.9 %id)
N41781 placenta .a 432 to 794 1 to 364       364/364
(100 %)
4 diff
(99.0 %id)
BQ674081 epidermoid carcinoma, cell line, salivary gland .a 463 to 1054 1 to 594       594/786
(75 %)
8 diff
(99.0 %id)
BQ671558 epidermoid carcinoma, cell line, salivary gland .a 463 to 1346 1 to 889       890/891
(99 %)
21 diff
(97.7 %id)
BE391982 endometrium, adenocarcinoma cell line, uterus .a 464 to 1009 15 to 559       545/559
(97 %)
7 diff
(98.8 %id)
BU194150 melanotic melanoma, skin .a 501 to 1259 37 to 795       759/900
(84 %)
31 diff
(96.6 %id)
BG697825 skin .a 505 to 1259 1 to 755       755/897
(84 %)
6 diff
(99.4 %id)
CB160153 Liver .a 507 to 1048 1 to 542       542/542
(100 %)
1 diff
(99.9 %id)
BE274643 melanotic melanoma, skin .a 514 to 1331 1 to 805       784/805
(97 %)
21 diff
(97.4 %id)
BE304686 adenocarcinoma cell line, colon .a 518 to 1206 16 to 709       694/710
(97 %)
16 diff
(97.8 %id)
BU156155 melanotic melanoma, skin .a 528 to 1126 11 to 617       602/956
(62 %)
14 diff
(98.6 %id)
BE621203 epithelioid carcinoma, Pancreas .a 547 to 1195 1 to 648       648/650
(99 %)
15 diff
(97.7 %id)
CA774910 Pancreas, Purified pancreatic islet .a 569 to 1189 625 to 6     Submitted on the opposite strand 620/625
(99 %)
1 diff
(99.9 %id)
CB107772 Liver .a 572 to 1053 1 to 482       482/482
(100 %)
4 diff
(99.2 %id)
DA728149   .a 575 to 1357 2 to 792   capped   791/847
(93 %)
15 diff
(98.3 %id)
CV573457 cornea, eye .a 587 to 1219 1 to 632       632/633
(99 %)
3 diff
(99.6 %id)
CA774673 Pancreas, Purified pancreatic islet .a 596 to 1033 1 to 438     Submitted on the opposite strand 438/438
(100 %)
1 diff
(99.8 %id)
AL577991 placenta .a 600 to 1626 1031 to 11       1021/1035
(98 %)
21 diff
(98.0 %id)
BP290828 lung .a 603 to 1187 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
BX386698   .a 606 to 1640 1026 to 1       1026/1033
(99 %)
23 diff
(97.8 %id)
CN356161 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 607 to 1053 1 to 447       447/447
(100 %)
1 diff
(99.8 %id)
CF128451 Chondrosarcoma Lung Metastasis cell lines, lung .a 667 to 1333 1 to 669       669/669
(100 %)
4 diff
(99.5 %id)
TI_154194331   .a 667 to 1570 47 to 950       904/1065
(84 %)
14 diff
(98.7 %id)
BE905802 epithelioid carcinoma, Pancreas .a 688 to 1259 1 to 570       570/929
(61 %)
4 diff
(99.6 %id)
CD673302 eye, Iris .a 691 to 1255 1 to 565       565/565
(100 %)
10 diff
(98.3 %id)
BG254583 adenocarcinoma, cell line, Prostate .a 696 to 1532 1 to 830       830/974
(85 %)
27 diff
(97.3 %id)
BE617373 adenocarcinoma, colon .a 710 to 1346 1 to 637       637/639
(99 %)
13 diff
(98.0 %id)
BX094231 liver and spleen .a 717 to 1474 1 to 755       755/755
(100 %)
4 diff
(99.5 %id)
BM792418 Ascites, stomach .a 754 to 1259 1 to 507       507/510
(99 %)
6 diff
(98.9 %id)
TI_1948085886   .a 797 to 1578 908 to 126   fully sequenced,   783/908
(86 %)
7 diff
(99.3 %id)
CV347644 lung_normal .a 824 to 1404 1 to 581       581/581
(100 %)
15 diff
(97.5 %id)
BG819687 anaplastic oligodendroglioma with 1p/19qloss, brain .a 844 to 1414 10 to 580       571/580
(98 %)
6 diff
(99.0 %id)
TI_1948086053   .a 844 to 1578 857 to 122   fully sequenced,   736/857
(85 %)
2 diff
(99.8 %id)
CR620362 Placenta Cot 25-normalized .a 847 to 1905 1 to 1059   tiling clone,   1059/1059
(100 %)
0 diff
(100 %id)
BX338333 Placenta Cot 25-normalized .a 847 to 1391 1 to 545   fully sequenced,   545/545
(100 %)
3 diff
(99.5 %id)
BM796136 Ascites, stomach .a 860 to 1347 1 to 488       488/488
(100 %)
2 diff
(99.6 %id)
CK429738 eye, lacrimal gland .a 862 to 1480 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
BU931176 ovary, teratocarcinoma, cell line .a 890 to 1676 812 to 21   AAA Submitted on the opposite strand 792/920
(86 %)
9 diff
(99.1 %id)
AW083041 colon, moderately differentiated adenocarcinoma .a 895 to 1675 774 to 1       774/863
(89 %)
17 diff
(98.1 %id)
BQ673466 epidermoid carcinoma, cell line, salivary gland .a 895 to 1676 816 to 35   AAA Submitted on the opposite strand 782/897
(87 %)
29 diff
(96.8 %id)
TI_149294681   .a 896 to 1676 817 to 37   AAA   781/981
(79 %)
3 diff
(99.7 %id)
TI_227712823   .a 900 to 1674 893 to 123   AAA   771/1005
(76 %)
8 diff
(99.3 %id)
AA402156 ovarian tumor, ovary .a 915 to 1391 1 to 476   fully sequenced,   476/476
(100 %)
1 diff
(99.8 %id)
BM794956 Ascites, stomach .a 935 to 1619 1 to 685       685/685
(100 %)
1 diff
(99.9 %id)
TI_154128794   .a 941 to 1676 818 to 84   AAA   735/736
(99 %)
5 diff
(99.4 %id)
BX333316 Neuroblastoma Cot 25-normalized .a 943 to 1621 681 to 1   fully sequenced,   681/681
(100 %)
13 diff
(98.1 %id)
BM791977 Ascites, stomach .a 944 to 1495 1 to 551       551/551
(100 %)
4 diff
(99.3 %id)
BI818257 pooled brain, lung, testis .a 948 to 1658 1 to 711       711/711
(100 %)
0 diff
(100 %id)
TI_57196061   .a 948 to 1658 35 to 745       711/745
(95 %)
10 diff
(98.7 %id)
BM827154 Ascites, stomach .a 948 to 1206 1 to 259       259/259
(100 %)
1 diff
(99.7 %id)
BU623923 cell lines, Enchondroma .a 949 to 1676 746 to 19   AAA   728/728
(100 %)
2 diff
(99.8 %id)
D16964   .a 953 to 1120 1 to 168       168/168
(100 %)
3 diff
(98.3 %id)
CN356159 embryonic stem cells, cell lines H1, H7, andH9 .a 971 to 1661 26 to 717       694/717
(96 %)
7 diff
(99.1 %id)
BI522263 pooled pancreas and spleen .a 971 to 1599 633 to 1       633/920
(68 %)
13 diff
(98.6 %id)
BU683322 lung .a 971 to 1676 722 to 17   AAA   706/712
(99 %)
2 diff
(99.8 %id)
DA540110 lung .a 977 to 1447 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
BM974153 lung .a 978 to 1676 715 to 17   AAA   699/699
(100 %)
3 diff
(99.6 %id)
BM978058 lung .a 978 to 1676 716 to 18   AAA   699/699
(100 %)
0 diff
(100 %id)
BU620457 cell lines, Chondrosarcoma .a 978 to 1676 718 to 19   AAA   700/700
(100 %)
2 diff
(99.8 %id)
CA310536 Human Lung Epithelial cells, lung .a 979 to 1676 713 to 17   AAA   697/697
(100 %)
3 diff
(99.6 %id)
CA417728 Chondrosarcoma Cell line .a 979 to 1676 713 to 17   AAA   697/697
(100 %)
3 diff
(99.6 %id)
CD370909 Alveolar Macrophage, lung .a 979 to 1674 713 to 19   AAA   695/695
(100 %)
2 diff
(99.8 %id)
CB529875 Aveolar Macrophage, lung .a 979 to 1676 714 to 17   AAA   698/698
(100 %)
6 diff
(99.2 %id)
TI_159722588   .a 1001 to 1678 763 to 87   AAA   677/979
(69 %)
1 diff
(99.9 %id)
TI_159722589   .a 1001 to 1678 765 to 87   AAA   679/959
(70 %)
1 diff
(99.9 %id)
CA944547 Human Lung Epithelial cells, lung .a 1001 to 1678 695 to 19   AAA   677/681
(99 %)
1 diff
(99.9 %id)
AI097079   .a 1004 to 1677 681 to 8       674/681
(98 %)
0 diff
(100 %id)
AI590653 normal gingiva (cell line from immortalizedkeratinocytes) .a 1004 to 1673 681 to 12   AAA   670/670
(100 %)
3 diff
(99.6 %id)
CR624047 Placenta Cot 25-normalized .a 1008 to 1677 1 to 670       670/670
(100 %)
0 diff
(100 %id)
BX338171 Placenta Cot 25-normalized .a 1008 to 1677 1 to 670   fully sequenced,   670/670
(100 %)
1 diff
(99.9 %id)
AI184598   .a 1016 to 1675 661 to 3       659/661
(99 %)
7 diff
(99.0 %id)
CA422964 cell lines, Chondrosarcoma .a 1020 to 1676 676 to 19   AAA   658/658
(100 %)
1 diff
(99.9 %id)
BQ674601 epidermoid carcinoma, cell line, salivary gland .a 1035 to 1676 1 to 643   AAA   643/643
(100 %)
1 diff
(99.9 %id)
CB528378 Aveolar Macrophage, lung .a 1040 to 1676 653 to 17   AAA   637/637
(100 %)
0 diff
(100 %id)
AI834220 head_neck .a 1044 to 1304 261 to 1       261/263
(99 %)
3 diff
(98.9 %id)
CA944548 Human Lung Epithelial cells, lung .a 1060 to 1678 635 to 17   AAA   619/619
(100 %)
0 diff
(100 %id)
BP430792   .a 1072 to 1420 1 to 349       349/349
(100 %)
4 diff
(98.9 %id)
EC569151 Prostate .a 1089 to 1178 89 to 1       89/89
(100 %)
1 diff
(98.9 %id)
BG236475 blood, lymphocyte .a 1103 to 1677 575 to 1       575/575
(100 %)
3 diff
(99.5 %id)
BQ446369 Knee, Osteoarthritic Cartilage .a 1129 to 1677 566 to 18       549/566
(96 %)
1 diff
(99.9 %id)
CB529505 Aveolar Macrophage, lung .a 1129 to 1674 560 to 15   AAA   546/546
(100 %)
11 diff
(98.0 %id)
H41389 brain .a 1132 to 1430 1 to 298   fully sequenced,   298/298
(100 %)
2 diff
(99.4 %id)
CD742861 Alveolar Macrophage, lung .a 1132 to 1674 557 to 15   AAA   543/543
(100 %)
1 diff
(99.9 %id)
BF114892 fibrotheoma, ovary .a 1133 to 1677 546 to 2       545/546
(99 %)
0 diff
(100 %id)
BG230741 blood, lymphocyte .a 1133 to 1677 549 to 5       545/549
(99 %)
5 diff
(99.1 %id)
BF434609 fibrotheoma, ovary .a 1136 to 1677 543 to 2       542/543
(99 %)
2 diff
(99.7 %id)
AI338416   .a 1142 to 1676 545 to 11   AAA   535/535
(100 %)
4 diff
(99.3 %id)
AI553746 anaplastic oligodendroglioma, brain .a 1142 to 1677 542 to 7       536/542
(98 %)
0 diff
(100 %id)
AA829463 colon, colon tumor .a 1145 to 1675 535 to 1       535/535
(100 %)
12 diff
(97.8 %id)
AI312079 lung .a 1145 to 1677 533 to 1       533/533
(100 %)
5 diff
(99.1 %id)
AI955646 adenocarcinoma, Pancreas .a 1145 to 1676 563 to 32   AAA   532/535
(99 %)
18 diff
(96.7 %id)
AI282879 colon, moderately-differentiated adenocarcinoma .a 1147 to 1677 534 to 3       532/538
(98 %)
6 diff
(98.9 %id)
AI128158 uterus .a 1148 to 1674 527 to 1       527/527
(100 %)
6 diff
(98.9 %id)
BQ013841 placenta .a 1164 to 1676 528 to 16   AAA   513/521
(98 %)
0 diff
(100 %id)
AA826623 colon, colon tumor .a 1166 to 1677 515 to 4       512/515
(99 %)
5 diff
(99.1 %id)
AI332670 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1169 to 1677 511 to 3       509/511
(99 %)
4 diff
(99.3 %id)
AW129552 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1169 to 1677 512 to 4       509/512
(99 %)
0 diff
(100 %id)
AI587286 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1181 to 1677 500 to 4       497/500
(99 %)
2 diff
(99.6 %id)
AA847385 colon, colon tumor .a 1187 to 1677 494 to 4       491/494
(99 %)
2 diff
(99.6 %id)
BE256864 eye, retinoblastoma .a 1197 to 1677 1 to 481       481/582
(82 %)
1 diff
(99.9 %id)
DB527486 testis .a 1200 to 1676 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
DB573336 hypothalamus .a 1201 to 1676 1 to 476     Submitted on the opposite strand 476/476
(100 %)
2 diff
(99.6 %id)
AA593817 colon, colon tumor .a 1203 to 1674 482 to 11   AAA   472/472
(100 %)
1 diff
(99.8 %id)
AA568187 colon, colon tumor RER+ .a 1205 to 1676 482 to 11   AAA   472/472
(100 %)
2 diff
(99.6 %id)
AA582466 Kidney, kidney tumor .a 1205 to 1676 472 to 1       472/472
(100 %)
10 diff
(97.9 %id)
AA974349 pooled germ cell tumors .a 1214 to 1677 464 to 1       464/464
(100 %)
1 diff
(99.8 %id)
AI830479 Kidney .a 1214 to 1676 463 to 1       463/466
(99 %)
3 diff
(99.4 %id)
BE328866 carcinoid, lung .a 1214 to 1677 466 to 3       464/466
(99 %)
6 diff
(98.8 %id)
BQ013019 placenta .a 1219 to 1676 473 to 17   AAA   457/457
(100 %)
0 diff
(100 %id)
AW236039 Kidney .a 1222 to 1660 439 to 1       439/448
(97 %)
0 diff
(100 %id)
AA582682 Kidney, kidney tumor .a 1223 to 1677 455 to 1       455/455
(100 %)
2 diff
(99.6 %id)
DB565164 hypothalamus .a 1225 to 1676 1 to 452     Submitted on the opposite strand 452/452
(100 %)
2 diff
(99.6 %id)
AA378324 synovial membrane .a 1230 to 1353 1 to 124       124/124
(100 %)
0 diff
(100 %id)
AW958229   .a 1231 to 1733 1 to 499       499/499
(100 %)
13 diff
(97.4 %id)
DB519504 testis .a 1234 to 1676 1 to 443     Submitted on the opposite strand 443/443
(100 %)
0 diff
(100 %id)
AA513420 breast .a 1235 to 1676 463 to 22   AAA   442/442
(100 %)
3 diff
(99.4 %id)
AA558042 bone marrow, stem cells .a 1235 to 1677 446 to 1       446/446
(100 %)
6 diff
(98.7 %id)
DB535098 hippocampus .a 1237 to 1676 1 to 440     Submitted on the opposite strand 440/440
(100 %)
2 diff
(99.6 %id)
AI189950 placenta .a 1244 to 1677 436 to 3       434/436
(99 %)
2 diff
(99.6 %id)
DB521057 testis .a 1249 to 1674 1 to 426     Submitted on the opposite strand 426/426
(100 %)
0 diff
(100 %id)
BM553917 brain, medulla .a 1252 to 1676 32 to 456   AAA   430/456
(94 %)
6 diff
(98.7 %id)
FN127486 breast carcinoma .a 1259 to 1326 69 to 1     Submitted on the opposite strand 69/69
(100 %)
0 diff
(100 %id)
T96356 liver and spleen .a 1266 to 1677 418 to 1       418/418
(100 %)
6 diff
(98.6 %id)
AI355102 colon, moderately-differentiated adenocarcinoma .a 1269 to 1677 410 to 1       410/413
(99 %)
8 diff
(98.1 %id)
BM993008 lung, Metastatic Chondrosarcoma .a 1269 to 1676 424 to 17   AAA   408/408
(100 %)
1 diff
(99.8 %id)
AA557978 bone marrow, stem cells .a 1274 to 1662 1 to 388       388/388
(100 %)
3 diff
(99.3 %id)
AI273949 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1274 to 1675 408 to 7       402/408
(98 %)
0 diff
(100 %id)
AI291019 carcinoid, lung .a 1303 to 1677 375 to 1       375/375
(100 %)
1 diff
(99.8 %id)
AA477162 ovarian tumor, ovary .a 1304 to 1391 1 to 88   fully sequenced,   88/88
(100 %)
0 diff
(100 %id)
AA405997 ovarian tumor, ovary .a 1304 to 1660 1 to 358       358/358
(100 %)
1 diff
(99.8 %id)
AA459166 ovarian tumor, ovary .a 1304 to 1671 1 to 368       368/368
(100 %)
0 diff
(100 %id)
AA486481 ovarian tumor, ovary .a 1304 to 1664 1 to 361       361/361
(100 %)
2 diff
(99.5 %id)
BX338170 Placenta Cot 25-normalized .a 1330 to 1621 293 to 1   fully sequenced,   293/293
(100 %)
2 diff
(99.4 %id)
BX338332 Placenta Cot 25-normalized .a 1330 to 1905 577 to 1   fully sequenced,   577/577
(100 %)
9 diff
(98.5 %id)
AA479662 ovarian tumor, ovary .a 1330 to 1675 356 to 11   fully sequenced,   346/356
(97 %)
0 diff
(100 %id)
AA402037 ovarian tumor, ovary .a 1330 to 1674 344 to 1   fully sequenced,   344/344
(100 %)
1 diff
(99.8 %id)
AW245383 lung, small cell carcinoma .a 1330 to 1676 357 to 11   available from MGC, AAA   347/377
(92 %)
2 diff
(99.5 %id)
BG992210 head_neck .a 1331 to 1526 227 to 32       196/227
(86 %)
1 diff
(99.6 %id)
AI142736 pooled .a 1340 to 1674 345 to 12   AAA   334/334
(100 %)
1 diff
(99.8 %id)
BQ230792 embryonal carcinoma, cell line, testis .a 1345 to 1676 1 to 332   AAA   332/332
(100 %)
0 diff
(100 %id)
AA580872 bulk germ cell seminoma .a 1346 to 1677 334 to 3       332/337
(98 %)
0 diff
(100 %id)
AA404661 ovarian tumor, ovary .a 1349 to 1674 338 to 12   AAA   327/327
(100 %)
1 diff
(99.7 %id)
AA470346   .a 1355 to 1675 329 to 9       321/329
(97 %)
0 diff
(100 %id)
AA991368 breast .a 1359 to 1481 123 to 1       123/124
(99 %)
2 diff
(98.4 %id)
AA962692 colon, colon tumor .a 1361 to 1642 281 to 1       281/290
(96 %)
2 diff
(99.4 %id)
AW299341 Kidney .a 1361 to 1676 316 to 1       316/316
(100 %)
0 diff
(100 %id)
BG191285   .a 1367 to 1675 1 to 308       308/311
(99 %)
8 diff
(97.5 %id)
BU857874 adenocarcinoma, cell line, breast .a 1375 to 1674 1 to 299   AAA   299/299
(100 %)
1 diff
(99.7 %id)
F29522 pectoral muscle (after mastectomy) .a 1380 to 1674 1 to 295       295/295
(100 %)
5 diff
(98.4 %id)
R47923 breast .a 1383 to 1529 157 to 10       148/157
(94 %)
0 diff
(100 %id)
H41390 brain .a 1400 to 1658 260 to 1   fully sequenced,   260/260
(100 %)
1 diff
(99.7 %id)
AI758477 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1413 to 1676 275 to 12   AAA   264/265
(99 %)
2 diff
(99.3 %id)
BM718577 eye, fetal eye .a 1432 to 1676 1 to 245   AAA   245/245
(100 %)
0 diff
(100 %id)
AA436129   .a 1455 to 1675 1 to 221   fully sequenced,   221/221
(100 %)
0 diff
(100 %id)
AI471021 brain, glioblastoma (pooled) .a 1477 to 1674 198 to 1       198/198
(100 %)
0 diff
(100 %id)
AA436022   .a 1498 to 1677 187 to 8   fully sequenced,   180/187
(96 %)
0 diff
(100 %id)
AI419177 brain, glioblastoma (pooled) .a 1500 to 1674 175 to 1       175/175
(100 %)
0 diff
(100 %id)
AI990214 pooled germ cell tumors .a 1616 to 1670 55 to 1       55/55
(100 %)
1 diff
(98.2 %id)
CN356167 embryonic stem cells, cell lines H1, H7, andH9 .b 1 to 556 1 to 556   tiling clone,   556/556
(100 %)
3 diff
(99.5 %id)
AK001777 ovarian cancer .b 76 to 1918 1 to 1842 S2C V258A V408A K409R V410S ... available from FLJ,   1842/1842
(100 %)
4 diff
(99.8 %id)
NM_012100.2   .b 76 to 2513 1 to 2438 V258A RefSeq,   2438/2438
(100 %)
1 diff
(100.0 %id)
DA272217 caudate nucleus .b 78 to 623 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA693583   .b 81 to 645 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BG721065 testis .b 83 to 692 1 to 611       611/611
(100 %)
4 diff
(99.4 %id)
CB995014 placenta, pre-eclamptic placenta .b 87 to 806 28 to 750       723/835
(86 %)
33 diff
(96.1 %id)
BP268706 thyroid .b 87 to 669 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CR590433 T cells (Jurkat cell line) Cot10-normalized .b 88 to 1459 1 to 1372       1372/1372
(100 %)
0 diff
(100 %id)
BX364656.
matches multiple genes
placenta, Placenta Cot 25-normalized .b 88 to 886 1 to 799     also hits gene FXR1 799/799
(100 %)
2 diff
(99.8 %id)
TI_57236799   .b 89 to 888 31 to 832       802/836
(95 %)
15 diff
(98.3 %id)
BU854894 ovary, teratocarcinoma, cell line .b 91 to 894 1 to 808       808/948
(85 %)
16 diff
(98.4 %id)
CR620682 neuroblastoma .b 94 to 1759 1 to 1666 exact     1666/1666
(100 %)
0 diff
(100 %id)
BX447228 neuroblastoma .b 94 to 918 1 to 825   fully sequenced,   825/825
(100 %)
0 diff
(100 %id)
BI908494 leukocyte .b 94 to 888 1 to 797       797/801
(99 %)
10 diff
(98.8 %id)
BI916721 brain .b 94 to 845 1 to 759       759/760
(99 %)
15 diff
(98.1 %id)
BI917707 brain .b 94 to 939 1 to 858       813/858
(94 %)
27 diff
(96.9 %id)
TI_57219703   .b 95 to 778 68 to 750       683/750
(91 %)
7 diff
(99.1 %id)
BI752879 brain .b 96 to 778 1 to 683       683/683
(100 %)
3 diff
(99.6 %id)
AL514384 neuroblastoma, placenta .b 101 to 1048 1 to 942   fully sequenced,   942/942
(100 %)
6 diff
(99.4 %id)
CR605526 neuroblastoma .b 101 to 1775 1 to 1675 exact tiling clone,   1675/1675
(100 %)
0 diff
(100 %id)
DR158884 human embryonic stem cells differentiated toan early endodermal cell type .b 102 to 780 1 to 679       679/679
(100 %)
0 diff
(100 %id)
DA812831 Pancreas .b 102 to 893 2 to 801   capped   800/838
(95 %)
16 diff
(98.1 %id)
BG420791 Kidney, renal cell adenocarcinoma .b 103 to 867 1 to 758       758/763
(99 %)
19 diff
(97.6 %id)
BI906979 leukocyte .b 103 to 887 1 to 785       785/785
(100 %)
5 diff
(99.4 %id)
TI_57233526   .b 103 to 887 29 to 813       785/813
(96 %)
10 diff
(98.8 %id)
AK001977 placenta .b 104 to 1774 1 to 1671 E129V V258A available from FLJ,   1671/1671
(100 %)
6 diff
(99.7 %id)
BG824075 adenocarcinoma cell line, colon .b 105 to 861 1 to 758       758/758
(100 %)
7 diff
(99.1 %id)
CX872946 embryonic stem .b 105 to 940 1 to 836       836/836
(100 %)
0 diff
(100 %id)
CB130358 Liver .b 105 to 423 1 to 319       319/319
(100 %)
0 diff
(100 %id)
AF005050   .b 106 to 1776 6 to 1676 V258A AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 1671/1676
(99 %)
7 diff
(99.6 %id)
DA344656 substantia nigra .b 106 to 670 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA530769 brain .b 106 to 692 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA679719   .b 106 to 676 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA716969   .b 107 to 649 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BM019012 astrocytoma grade IV, cell line, brain .b 108 to 742 1 to 634       634/636
(99 %)
4 diff
(99.4 %id)
BU188365 melanotic melanoma, skin .b 109 to 878 11 to 789       779/925
(84 %)
26 diff
(97.2 %id)
TI_59389690   .b 109 to 742 59 to 691       633/635
(99 %)
3 diff
(99.6 %id)
DC402739 testis .b 109 to 665 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DA040805 bladder .b 110 to 674 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA428070 colon .b 110 to 678 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
DR761659 embryonic stem .b 110 to 838 1 to 729       729/729
(100 %)
0 diff
(100 %id)
DA705291   .b 110 to 576 2 to 468   capped   467/467
(100 %)
0 diff
(100 %id)
DB037136 testis .b 110 to 682 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB206563 trachea .b 110 to 683 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BP266262 thyroid .b 111 to 693 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA071229 cerebellum .b 112 to 669 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BG114878 duodenal adenocarcinoma, cell line, small intestine .b 112 to 901 1 to 787       787/970
(81 %)
22 diff
(97.8 %id)
DN997978 breast cancer, Mammary gland (cancer tissue) .b 112 to 833 1 to 722       722/722
(100 %)
5 diff
(99.4 %id)
CR611309 B cells (Ramos cell line) Cot 25-normalized .b 114 to 1735 1 to 1622 exact     1622/1622
(100 %)
0 diff
(100 %id)
BX401446   .b 114 to 1026 1 to 912   fully sequenced,   912/912
(100 %)
3 diff
(99.7 %id)
BU521296 leiomyosarcoma, uterus .b 114 to 972 1 to 865       865/865
(100 %)
5 diff
(99.5 %id)
DR762440 embryonic stem .b 115 to 925 1 to 811       811/811
(100 %)
0 diff
(100 %id)
BU191471 ductal carcinoma, cell line, Pancreas .b 116 to 894 1 to 783       783/924
(84 %)
21 diff
(97.8 %id)
CR614945 neuroblastoma .b 118 to 1747 1 to 1630 exact     1630/1630
(100 %)
0 diff
(100 %id)
AL516777 brain, neuroblastoma, neuroblastoma cells .b 118 to 918 1 to 801   fully sequenced,   801/801
(100 %)
0 diff
(100 %id)
BI766855 pooled lung and spleen .b 118 to 894 1 to 780       780/822
(94 %)
9 diff
(99.0 %id)
TI_57180753   .b 118 to 894 32 to 811       780/853
(91 %)
14 diff
(98.4 %id)
BI769510 pooled lung and spleen .b 119 to 841 1 to 728       728/755
(96 %)
10 diff
(98.7 %id)
BQ430928 melanotic melanoma, skin .b 119 to 811 1 to 704       704/947
(74 %)
17 diff
(98.3 %id)
BQ686805 ductal carcinoma, cell line, Pancreas .b 119 to 809 1 to 695       695/842
(82 %)
13 diff
(98.5 %id)
TI_57182530   .b 119 to 841 69 to 796       728/823
(88 %)
16 diff
(98.1 %id)
TI_57236780   .b 119 to 965 28 to 879       852/879
(96 %)
17 diff
(98.1 %id)
BM454257 lymph, lymphoma, cell line .b 120 to 804 29 to 720       692/1151
(60 %)
19 diff
(98.4 %id)
DA632749 Kidney .b 121 to 688 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BQ068430 brain, neuroblastoma, cell line .b 122 to 901 19 to 805       787/1051
(74 %)
24 diff
(97.8 %id)
CR623295 Neuroblastoma Cot 10-normalized .b 123 to 1746 1 to 1624 exact     1624/1624
(100 %)
0 diff
(100 %id)
AL520409 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 123 to 1026 1 to 905   fully sequenced,   905/905
(100 %)
3 diff
(99.7 %id)
BQ709342 Spleen .b 123 to 888 1 to 766       766/932
(82 %)
11 diff
(98.9 %id)
BQ707848 Spleen .b 123 to 806 1 to 689       689/815
(84 %)
17 diff
(98.0 %id)
BQ706423 Spleen .b 123 to 888 1 to 771       771/956
(80 %)
17 diff
(98.3 %id)
CN356166 embryonic stem cells, cell lines H1, H7, andH9 .b 126 to 848 1 to 723       723/723
(100 %)
1 diff
(99.9 %id)
BE407183 choriocarcinoma, placenta .b 126 to 743 1 to 618       618/618
(100 %)
4 diff
(99.4 %id)
BE409425 choriocarcinoma, placenta .b 126 to 716 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BI908476 leukocyte .b 126 to 965 1 to 845       845/845
(100 %)
12 diff
(98.6 %id)
BG339799 leiomyosarcoma cell line, uterus .b 127 to 804 1 to 690       690/856
(80 %)
23 diff
(97.4 %id)
CF272389 Brain glioblastoma .b 127 to 975 1 to 853       853/908
(93 %)
11 diff
(98.8 %id)
TI_57232667   .b 127 to 939 25 to 837       813/837
(97 %)
13 diff
(98.5 %id)
BM917003 blood, natural killer cells, cell line .b 129 to 1080 1 to 961       961/1066
(90 %)
26 diff
(97.6 %id)
BX339529 Placenta Cot 25-normalized .b 130 to 775 1 to 646       646/646
(100 %)
0 diff
(100 %id)
AL558214 T cells from T cell leukemia .b 130 to 1006 1 to 878       878/925
(94 %)
16 diff
(98.3 %id)
CR593910 Placenta Cot 25-normalized .b 132 to 1725 1 to 1594 exact     1594/1594
(100 %)
0 diff
(100 %id)
BX357185 Placenta Cot 25-normalized .b 132 to 1026 1 to 895   fully sequenced,   895/895
(100 %)
2 diff
(99.8 %id)
BM923375 pooled colon, kidney, stomach .b 132 to 1073 20 to 970       951/1069
(88 %)
17 diff
(98.5 %id)
CN356164 embryonic stem cells, cell lines H1, H7, andH9 .b 133 to 836 13 to 716       704/716
(98 %)
6 diff
(99.2 %id)
BI907252 leukocyte .b 133 to 939 1 to 807       807/807
(100 %)
7 diff
(99.2 %id)
BE742366 adenocarcinoma cell line, ovary .b 134 to 975 1 to 840       840/1081
(77 %)
19 diff
(98.3 %id)
BF344238 brain, glioblastoma with EGFR amplification .b 136 to 853 1 to 717       717/717
(100 %)
9 diff
(98.8 %id)
TI_57146786   .b 144 to 811 29 to 696       668/706
(94 %)
8 diff
(98.9 %id)
TI_57234648   .b 144 to 931 29 to 818       790/818
(96 %)
16 diff
(98.1 %id)
CR607064 Neuroblastoma Cot 25-normalized .b 145 to 1746 1 to 1602 exact     1602/1602
(100 %)
0 diff
(100 %id)
AL524837 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 145 to 1026 1 to 881   fully sequenced,   881/881
(100 %)
4 diff
(99.6 %id)
BI761096 pooled colon, kidney, stomach .b 149 to 811 1 to 663       663/673
(98 %)
2 diff
(99.8 %id)
BI908726 leukocyte .b 149 to 931 1 to 785       785/785
(100 %)
10 diff
(98.8 %id)
BQ073010 leukocyte .b 150 to 996 1 to 854       854/1073
(79 %)
11 diff
(99.0 %id)
CX761325 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 150 to 888 1 to 737     Submitted on the opposite strand 737/741
(99 %)
4 diff
(99.5 %id)
BX396779 Placenta Cot 25-normalized .b 151 to 986 1 to 834       834/834
(100 %)
4 diff
(99.6 %id)
BM454789 leiomyosarcoma, uterus .b 151 to 811 1 to 661       661/1166
(56 %)
6 diff
(99.5 %id)
AK023005   .b 162 to 2425 1 to 2264 V258A R453W tiling clone, available from FLJ,   2264/2264
(100 %)
4 diff
(99.9 %id)
AU129252   .b 162 to 811 2 to 655   capped   654/688
(95 %)
9 diff
(98.7 %id)
BM920931 pooled brain, lung, testis .b 164 to 993 15 to 851       837/1065
(78 %)
19 diff
(98.3 %id)
DA644657   .b 170 to 742 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
TI_57187814   .b 178 to 893 49 to 779       727/791
(91 %)
30 diff
(96.3 %id)
TI_57188120   .b 178 to 946 26 to 794       769/769
(100 %)
2 diff
(99.8 %id)
CR608875 Placenta Cot 25-normalized .b 180 to 1772 1 to 1593 exact     1593/1593
(100 %)
0 diff
(100 %id)
BX359287 Placenta Cot 25-normalized .b 180 to 1050 1 to 870   fully sequenced,   870/870
(100 %)
4 diff
(99.6 %id)
BI859157 breast, mammary adenocarcinoma, cell line .b 180 to 946 1 to 767       767/767
(100 %)
2 diff
(99.8 %id)
BC000653 Eye, retinoblastoma .b 194 to 1918 1 to 1725 V258A available from MGC, AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 1725/1725
(100 %)
1 diff
(100.0 %id)
BG686168 B-cells, primary B-cells from tonsils (cell line) .b 203 to 931 1 to 730       730/730
(100 %)
6 diff
(99.2 %id)
BI826250 brain, medulla .b 205 to 986 1 to 780       780/780
(100 %)
3 diff
(99.7 %id)
TI_57173331   .b 205 to 986 29 to 808       780/808
(96 %)
9 diff
(98.9 %id)
BQ423219 melanotic melanoma, skin .b 206 to 963 26 to 784       759/885
(85 %)
20 diff
(97.8 %id)
CF126344 Chondrosarcoma Lung Metastasis cell lines, lung .b 207 to 979 1 to 771       771/771
(100 %)
2 diff
(99.8 %id)
TI_154189315   .b 207 to 997 51 to 838       788/1027
(76 %)
9 diff
(99.2 %id)
DA978599 synovial membrane tissue from rheumatioidarthritis .b 208 to 692 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
BM546168 ovary (pool of 3) .b 209 to 1154 1 to 951       951/1058
(89 %)
19 diff
(98.3 %id)
BI755275 brain .b 211 to 1113 1 to 908       908/936
(97 %)
19 diff
(98.0 %id)
BU162343 leiomyosarcoma, uterus .b 211 to 996 1 to 789       789/861
(91 %)
7 diff
(99.2 %id)
TI_57215461   .b 211 to 1080 35 to 909       875/970
(90 %)
26 diff
(97.4 %id)
BX473268   .b 217 to 885 1 to 670       670/670
(100 %)
4 diff
(99.5 %id)
BI457994 brain, hypothalamus .b 219 to 1034 1 to 816       816/817
(99 %)
17 diff
(98.0 %id)
BP196644 adrenal gland .b 220 to 802 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BP253876 Kidney .b 220 to 801 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA432257 colon .b 221 to 690 2 to 471   capped   470/470
(100 %)
0 diff
(100 %id)
DA588108 lung .b 221 to 771 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA766659 tongue .b 221 to 786 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA875304 Prostate .b 221 to 788 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB008562 cervix, tumor tissue .b 221 to 794 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DB189870 lung, tumor tissue .b 221 to 818 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DA359731 subthalamic nucleus .b 223 to 742 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
BY995350   .b 224 to 927 18 to 721       704/721
(97 %)
6 diff
(99.2 %id)
DA427547 colon .b 225 to 728 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
DA620285   .b 225 to 813 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
TI_57219808   .b 227 to 1053 67 to 893       827/951
(86 %)
17 diff
(98.3 %id)
TI_57219882   .b 227 to 959 58 to 793       736/1118
(65 %)
14 diff
(98.8 %id)
BG385874 adenocarcinoma cell line, colon .b 229 to 990 1 to 753       753/769
(97 %)
15 diff
(98.1 %id)
BI823360 pooled brain, lung, testis .b 229 to 987 1 to 764       764/939
(81 %)
8 diff
(99.2 %id)
TI_57202877   .b 229 to 1145 35 to 972       851/973
(87 %)
38 diff
(96.1 %id)
BE741783 adenocarcinoma cell line, ovary .b 230 to 954 7 to 731       725/731
(99 %)
6 diff
(99.2 %id)
DA651447   .b 230 to 764 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
BI819521 pooled brain, lung, testis .b 231 to 1154 1 to 924       924/1060
(87 %)
26 diff
(97.6 %id)
BQ437084 melanotic melanoma, skin .b 231 to 1074 1 to 847       847/879
(96 %)
6 diff
(99.4 %id)
TI_57199377   .b 231 to 1154 35 to 958       924/1094
(84 %)
32 diff
(97.1 %id)
BQ427473 melanotic melanoma, skin .b 232 to 1068 1 to 847       847/858
(98 %)
11 diff
(98.8 %id)
BU161684 melanotic melanoma, skin .b 232 to 996 1 to 768       768/874
(87 %)
7 diff
(99.2 %id)
DA065859 cerebellum .b 233 to 797 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
CR620845 Placenta Cot 25-normalized .b 233 to 1760 1 to 1528       1528/1528
(100 %)
0 diff
(100 %id)
BX387640 Placenta Cot 25-normalized .b 233 to 1104 1 to 876   fully sequenced,   876/876
(100 %)
4 diff
(99.6 %id)
BE895204 melanotic melanoma, skin .b 233 to 938 1 to 710       710/1107
(64 %)
12 diff
(99.0 %id)
BI753578 brain .b 233 to 1053 1 to 821       821/879
(93 %)
11 diff
(98.8 %id)
BI757018 brain .b 233 to 959 1 to 730       730/1055
(69 %)
9 diff
(99.2 %id)
BI521450 pooled pancreas and spleen .b 233 to 989 1 to 761       761/761
(100 %)
8 diff
(99.0 %id)
CF242834 Brain glioblastoma .b 233 to 997 1 to 765       765/855
(89 %)
4 diff
(99.6 %id)
CR601156 Neuroblastoma Cot 10-normalized .b 235 to 1761 1 to 1527       1527/1527
(100 %)
0 diff
(100 %id)
AL519463 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 235 to 1037 1 to 802   fully sequenced,   802/802
(100 %)
2 diff
(99.8 %id)
BQ957429 large cell carcinoma, lung .b 235 to 1126 1 to 901       899/908
(99 %)
11 diff
(98.8 %id)
BM926673 pooled lung and spleen .b 237 to 1154 10 to 934       923/1126
(81 %)
29 diff
(97.5 %id)
BE732795 choriocarcinoma, placenta .b 238 to 1050 1 to 818       818/946
(86 %)
16 diff
(98.4 %id)
BE901364 choriocarcinoma, placenta .b 238 to 1001 1 to 760       760/883
(86 %)
16 diff
(98.2 %id)
BE278232 choriocarcinoma, placenta .b 239 to 883 1 to 647       647/701
(92 %)
6 diff
(99.2 %id)
BE901027 choriocarcinoma, placenta .b 239 to 1044 1 to 807       807/890
(90 %)
26 diff
(97.1 %id)
TI_1948085739   .b 251 to 1026 131 to 906   fully sequenced,   776/906
(85 %)
3 diff
(99.7 %id)
TI_1948086206   .b 251 to 1026 127 to 905   fully sequenced,   779/905
(86 %)
6 diff
(99.4 %id)
CV029272 mixed .b 252 to 926 1 to 675       675/675
(100 %)
1 diff
(99.9 %id)
BP252185 Kidney .b 252 to 832 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BX447227 neuroblastoma .b 857 to 1739 901 to 19   fully sequenced,   883/901
(98 %)
8 diff
(99.2 %id)
AL516776 brain, neuroblastoma, neuroblastoma cells .b 857 to 1746 892 to 1   fully sequenced,   891/891
(100 %)
36 diff
(96.0 %id)
BX364655.
matches multiple genes
placenta, Placenta Cot 25-normalized .b 895 to 1741 847 to 1     also hits gene FXR1 847/847
(100 %)
18 diff
(97.9 %id)
AL520408 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 965 to 1732 778 to 12   fully sequenced,   767/778
(98 %)
4 diff
(99.5 %id)
AL562400 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 965 to 1735 779 to 10   fully sequenced,   770/779
(98 %)
10 diff
(98.8 %id)
BX357184 Placenta Cot 25-normalized .b 965 to 1725 759 to 1   fully sequenced,   759/759
(100 %)
7 diff
(99.1 %id)
BX401445   .b 965 to 1725 771 to 11   fully sequenced,   761/771
(98 %)
3 diff
(99.7 %id)
TI_1948085740   .b 965 to 1678 837 to 124   fully sequenced,   714/837
(85 %)
4 diff
(99.6 %id)
AL580097 T cells from T cell leukemia .b 990 to 1702 763 to 27       737/964
(76 %)
36 diff
(96.3 %id)
TI_1948086207   .b 995 to 1678 810 to 127   fully sequenced,   684/810
(84 %)
3 diff
(99.7 %id)
AL519462 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 1007 to 1761 754 to 1   fully sequenced,   754/754
(100 %)
1 diff
(99.9 %id)
AL514383 neuroblastoma, placenta .b 1018 to 1775 758 to 1   fully sequenced,   758/758
(100 %)
6 diff
(99.3 %id)
BX351899 Placenta Cot 25-normalized .b 1020 to 1767 751 to 5   fully sequenced,   747/751
(99 %)
1 diff
(99.9 %id)
BX387639 Placenta Cot 25-normalized .b 1043 to 1749 719 to 12   fully sequenced,   706/717
(98 %)
6 diff
(99.2 %id)
BX351576 Placenta Cot 25-normalized .b 1073 to 1775 704 to 1       704/899
(78 %)
8 diff
(99.2 %id)
TI_154113154   .b 1088 to 1918 928 to 107   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 822/925
(88 %)
10 diff
(99.0 %id)
TI_154102209   .b 1098 to 1918 896 to 81   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 816/939
(86 %)
5 diff
(99.5 %id)
CA445437 Chondrosarcoma, Left Pubic Bone .b 1167 to 1918 769 to 19   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 751/751
(100 %)
1 diff
(99.9 %id)
BX339528 Placenta Cot 25-normalized .b 1179 to 1885 706 to 1       706/706
(100 %)
1 diff
(99.9 %id)
CA448742 Chondrosarcoma, Left Pelvis .b 1254 to 1918 683 to 19   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 665/665
(100 %)
0 diff
(100 %id)
BG107875 Bone, osteosarcoma, cell line .b 1263 to 1895 1 to 637   AAA   637/666
(95 %)
7 diff
(99.0 %id)
AA767229 germinal center B cell .b 1266 to 1918 680 to 30   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 649/651
(99 %)
17 diff
(97.4 %id)
BG260801 bladder, transitional cell papilloma, cell line .b 1282 to 2064 12 to 805       794/906
(87 %)
33 diff
(96.4 %id)
DB327483 Pancreas .b 1357 to 1776 421 to 1       421/469
(89 %)
1 diff
(99.8 %id)
CA396261 eye, RPE/choroid .b 1474 to 1966 1 to 493       493/493
(100 %)
0 diff
(100 %id)
BQ029776 lung, Metastatic Chondrosarcoma .b 1521 to 1919 417 to 19   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 399/399
(100 %)
0 diff
(100 %id)
BQ030147 lung, Metastatic Chondrosarcoma .b 1591 to 1919 347 to 19   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 329/329
(100 %)
0 diff
(100 %id)
AW044568 pooled .b 1633 to 1917 285 to 1       285/285
(100 %)
0 diff
(100 %id)
CN315262 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1761 to 2513 13 to 766   tiling clone,   754/766
(98 %)
6 diff
(99.3 %id)
AA299466 uterus .b 1824 to 2081 1 to 258       258/258
(100 %)
0 diff
(100 %id)
AU151411   .b 1896 to 2425 530 to 1       530/534
(99 %)
9 diff
(98.4 %id)
BM564135 brain, medulla .c 1 to 1048 17 to 1061   tiling clone,   1045/1077
(97 %)
24 diff
(97.8 %id)
AL046619 testis .c 866 to 1352 1 to 489   tiling clone,   489/489
(100 %)
3 diff
(99.4 %id)
BE887724 leiomyosarcoma, uterus .c 1558 to 2359 1 to 803   tiling clone,   803/859
(93 %)
34 diff
(96.1 %id)
EB386661 eye, optic nerve .c 1631 to 2250 1 to 619       619/619
(100 %)
5 diff
(99.2 %id)
DB348987.
matches multiple genes
trachea .c 1635 to 2190 556 to 1     also hits gene blersmu 556/556
(100 %)
1 diff
(99.9 %id)
BU951132 Pancreas, Purified pancreatic islet .c 1659 to 2096 1 to 438       438/438
(100 %)
4 diff
(99.1 %id)
CA776627 Pancreas, Purified pancreatic islet .c 1690 to 2147 1 to 458   fully sequenced, AAA   458/458
(100 %)
2 diff
(99.6 %id)
BF738382 bladder_tumor .c 1896 to 2288 399 to 8     Submitted on the opposite strand 392/399
(98 %)
0 diff
(100 %id)
AL046620 testis .c 2081 to 2674 591 to 2   tiling clone,   590/591
(99 %)
0 diff
(100 %id)
CA776392 Pancreas, Purified pancreatic islet .c 2117 to 2649 532 to 1   tiling clone, fully sequenced,   532/532
(100 %)
13 diff
(97.6 %id)
BU952569 Pancreas, Purified pancreatic islet .c 2494 to 2650 156 to 1       156/156
(100 %)
1 diff
(99.4 %id)
BP422294 small intestine .c 2642 to 3165 1 to 524   tiling clone, Submitted on the opposite strand 524/524
(100 %)
4 diff
(99.3 %id)
T20055   .c 2711 to 2918 1 to 208       208/208
(100 %)
3 diff
(98.6 %id)
R73217 breast .c 2871 to 3092 1 to 225       225/228
(98 %)
13 diff
(94.3 %id)
AW769066 colon, moderately-differentiated adenocarcinoma .c 2923 to 3187 265 to 1       265/265
(100 %)
0 diff
(100 %id)
AW769434 colon, moderately-differentiated adenocarcinoma .c 2924 to 3190 267 to 1       267/267
(100 %)
0 diff
(100 %id)
BM989500 lung, Metastatic Chondrosarcoma .c 2985 to 3567 601 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 583/596
(97 %)
2 diff
(99.7 %id)
AW265186 colon, colonic adenocarcinoma .c 3198 to 3669 34 to 505   tiling clone, Submitted on the opposite strand 472/505
(93 %)
6 diff
(98.9 %id)
AW265244 colon, colonic adenocarcinoma .c 3198 to 3551 22 to 375     Submitted on the opposite strand 354/375
(94 %)
6 diff
(98.4 %id)
AL135352 melanoma (MeWo cell line) .c 3207 to 3696 1 to 500   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 500/500
(100 %)
15 diff
(97.0 %id)
BM689720 eye, Retina Foveal and Macular .c 3239 to 3691 8 to 461   fully sequenced, Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 454/461
(98 %)
6 diff
(98.7 %id)
AI086530 senescent fibroblast .c 3283 to 3697 422 to 8       415/422
(98 %)
0 diff
(100 %id)
BM661690 eye, Retina Foveal and Macular .c 3285 to 3706 441 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 423/423
(100 %)
5 diff
(98.9 %id)
AW338201 adenocarcinoma, Pancreas .c 3289 to 3696 408 to 1       408/408
(100 %)
3 diff
(99.3 %id)
BP398286 pancreatic islet .c 3482 to 3706 7 to 231     Submitted on the opposite strand 225/231
(97 %)
6 diff
(97.5 %id)
BF799410 colon_ins .c 3528 to 3804 25 to 300   tiling clone,   276/313
(88 %)
11 diff
(96.5 %id)
CR603497 HeLa cells Cot 25-normalized .d 44 to 1762 1 to 1719 exact tiling clone,   1719/1719
(100 %)
0 diff
(100 %id)
AL555511 placenta .d 57 to 1095 14 to 1052       1039/1052
(98 %)
9 diff
(99.2 %id)
BX386699   .d 57 to 1078 14 to 1033       1020/1043
(97 %)
17 diff
(98.4 %id)
BP198156 adrenal gland .d 59 to 640 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA550704   .d 60 to 522 2 to 464   capped   463/464
(99 %)
1 diff
(99.8 %id)
DA612343   .d 61 to 619 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BP296525   .d 62 to 644 1 to 583       583/583
(100 %)
7 diff
(98.8 %id)
DB247468 uterus .d 62 to 619 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA825164 pericardium .d 64 to 563 2 to 502   capped   501/501
(100 %)
1 diff
(99.9 %id)
BX403948 neuroblastoma .d 66 to 1181 1 to 1107       1107/1107
(100 %)
18 diff
(98.4 %id)
AL526402 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 66 to 940 1 to 873   fully sequenced,   873/873
(100 %)
4 diff
(99.6 %id)
BP202974 coronary artery .d 67 to 646 1 to 580       580/580
(100 %)
0 diff
(100 %id)
CR595452 Neuroblastoma Cot 25-normalized .d 67 to 1744 1 to 1678 exact     1678/1678
(100 %)
0 diff
(100 %id)
BP350114 brain .d 67 to 650 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
CR616703 neuroblastoma .d 95 to 1797 1 to 1703 exact tiling clone,   1703/1703
(100 %)
0 diff
(100 %id)
BX457642 neuroblastoma .d 95 to 1126 1 to 1028   fully sequenced,   1028/1028
(100 %)
5 diff
(99.6 %id)
AA143590 colon, tumor .d 96 to 629 1 to 534       534/536
(99 %)
16 diff
(97.1 %id)
BM912474 amelanotic melanoma, cell line, skin .d 96 to 378 1 to 283       283/1371
(20 %)
4 diff
(99.8 %id)
CV571531 cornea, eye .d 102 to 583 1 to 482       482/482
(100 %)
0 diff
(100 %id)
BG752296 eye, normal pigmented retinal epithelium .d 104 to 917 1 to 822       822/938
(87 %)
28 diff
(97.1 %id)
DA026851   .d 124 to 681 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BI772427 pooled lung and spleen .d 280 to 495 363 to 578       523/578
(90 %)
6 diff
(99.0 %id)
TI_57180000   .d 280 to 495 393 to 608       523/608
(86 %)
6 diff
(99.1 %id)
AL562665 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 879 to 1734 868 to 11   fully sequenced,   858/868
(98 %)
21 diff
(97.6 %id)
BX411979 neuroblastoma .d 1093 to 1797 706 to 1   fully sequenced,   706/706
(100 %)
9 diff
(98.8 %id)
AA143591 colon, tumor .d 1240 to 1798 565 to 1   tiling clone,   565/565
(100 %)
12 diff
(97.9 %id)
BX433704 neuroblastoma .d 1337 to 1793 456 to 1       456/701
(65 %)
12 diff
(98.3 %id)
BG503785 embryonal carcinoma, testis .e 1 to 694 1 to 690   tiling clone,   690/696
(99 %)
10 diff
(98.6 %id)
DB467946 hippocampus .e 2 to 460 1 to 461       459/463
(99 %)
5 diff
(99.0 %id)
CR599387 Neuroblastoma Cot 10-normalized .e 13 to 1643 1 to 1631 exact     1631/1631
(100 %)
0 diff
(100 %id)
AL519865 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 13 to 909 1 to 897   fully sequenced,   897/897
(100 %)
4 diff
(99.6 %id)
DR006931 Spleen .e 23 to 709 9 to 695       687/695
(98 %)
6 diff
(99.2 %id)
DA564728 heart .e 27 to 585 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BM546018 ovary (pool of 3) .e 29 to 1048 18 to 1037       1020/1120
(91 %)
25 diff
(97.8 %id)
AA115821 colon, tumor .e 49 to 475 1 to 421       421/426
(98 %)
20 diff
(95.4 %id)
BE273280 Kidney, renal cell adenocarcinoma .e 62 to 696 1 to 636       636/710
(89 %)
17 diff
(97.7 %id)
AA380905   .e 110 to 427 1 to 316       316/317
(99 %)
6 diff
(98.2 %id)
CR605917 placenta .e 115 to 1658 1 to 1544 exact tiling clone,   1544/1544
(100 %)
0 diff
(100 %id)
BG421019 Kidney, renal cell adenocarcinoma .e 122 to 858 1 to 742       742/868
(85 %)
26 diff
(97.1 %id)
DA552525   .e 136 to 714 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA587242 lung .e 136 to 692 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BE617139 adenocarcinoma, colon .e 139 to 831 1 to 688       688/690
(99 %)
9 diff
(98.7 %id)
BX403586 placenta .e 146 to 1014 35 to 901   fully sequenced,   867/901
(96 %)
19 diff
(97.9 %id)
BM006223 hepatocellular carcinoma, cell line, Liver .e 147 to 836 1 to 689       689/691
(99 %)
8 diff
(98.9 %id)
TI_59386179   .e 148 to 836 62 to 749       688/690
(99 %)
7 diff
(99.0 %id)
AA085284   .e 149 to 601 1 to 452       452/454
(99 %)
7 diff
(98.5 %id)
BQ653818 hepatocellular carcinoma, cell line, Liver .e 150 to 893 1 to 745       745/934
(79 %)
9 diff
(99.1 %id)
BQ646395 hepatocellular carcinoma, cell line, Liver .e 150 to 944 1 to 802       802/968
(82 %)
17 diff
(98.3 %id)
BM797561 Ascites, stomach .e 150 to 604 1 to 455       455/455
(100 %)
3 diff
(99.4 %id)
AL519864 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 848 to 1643 794 to 1   fully sequenced,   794/794
(100 %)
10 diff
(98.8 %id)
BX433546 placenta .e 984 to 1658 675 to 1   fully sequenced,   675/675
(100 %)
3 diff
(99.6 %id)
AA115822 colon, tumor .e 1211 to 1658 456 to 6       451/457
(98 %)
3 diff
(99.4 %id)
AA085218   .e 1287 to 1660 376 to 2   tiling clone,   375/376
(99 %)
1 diff
(99.8 %id)
AW245740 lung, small cell carcinoma .f 1 to 640 9 to 648   tiling clone, available from MGC,   640/648
(98 %)
6 diff
(99.1 %id)
BC003040 Lung, small cell carcinoma .f 2 to 1578 1 to 1576 P165L L166S N167M A168L V169W ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 1576/1576
(100 %)
2 diff
(99.9 %id)
AA314649 colon .f 94 to 343 1 to 250       250/250
(100 %)
2 diff
(99.2 %id)
BM700365 eye, lens .f 238 to 831 1 to 594     Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 594/594
(100 %)
1 diff
(99.9 %id)
CR601748 Neuroblastoma Cot 50-normalized .f 315 to 1560 1 to 1246   tiling clone,   1246/1246
(100 %)
0 diff
(100 %id)
AL530996 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .f 315 to 990 1 to 676   fully sequenced,   676/676
(100 %)
1 diff
(99.9 %id)
BC004854 Ovary, adenocarcinoma .f 430 to 1578 86 to 1234   available from MGC, AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 1149/1234
(93 %)
7 diff
(99.5 %id)
BM710645 eye, fetal eyes .f 603 to 883 1 to 281     Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 281/281
(100 %)
1 diff
(99.7 %id)
H52913 liver and spleen .f 619 to 1023 1 to 407       407/467
(87 %)
10 diff
(97.9 %id)
TI_149291539   .f 629 to 1578 993 to 59   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 935/944
(99 %)
27 diff
(97.2 %id)
TI_149312487   .f 725 to 1578 934 to 87   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 848/966
(87 %)
10 diff
(99.0 %id)
BE617838 adenocarcinoma, colon .f 738 to 1564 826 to 4       823/826
(99 %)
4 diff
(99.6 %id)
BX383018   .f 739 to 1527 807 to 17       790/876
(90 %)
27 diff
(97.0 %id)
BU738018 eye, lens .f 924 to 1578 671 to 17   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 655/655
(100 %)
1 diff
(99.9 %id)
AL563909 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .f 929 to 1560 632 to 1   fully sequenced,   632/632
(100 %)
2 diff
(99.7 %id)
BM667365 eye, fetal eyes .f 1121 to 1576 474 to 19   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 456/456
(100 %)
0 diff
(100 %id)
H52914 liver and spleen .f 1161 to 1574 420 to 1       420/424
(99 %)
9 diff
(97.9 %id)
AK302809 testis .g 1 to 1379 1 to 1379 V258A tiling clone,   1379/1379
(100 %)
2 diff
(99.9 %id)
AK021871 whole embryo, mainly head .g 116 to 1725 1 to 1610   tiling clone, available from FLJ,   1610/1610
(100 %)
4 diff
(99.8 %id)
AU119645 whole embryo, mainly head .g 117 to 888 2 to 773   capped   772/772
(100 %)
9 diff
(98.9 %id)
BF756594 colon .g 620 to 1019 413 to 14     Submitted on the opposite strand 400/413
(96 %)
0 diff
(100 %id)
AU145932 whole embryo, mainly head .g 1177 to 1725 546 to 1       546/580
(94 %)
11 diff
(98.2 %id)
BI256589 cervical carcinoma cell line, cervix .h 1 to 841 1 to 841 F86L A87L V88* tiling clone,   839/842
(99 %)
16 diff
(98.1 %id)
BX400033   .i 1 to 922 4 to 918   tiling clone,   918/918
(100 %)
12 diff
(98.7 %id)
DA398660 thalamus .j 1 to 519 2 to 520   tiling clone, capped   519/519
(100 %)
0 diff
(100 %id)
BI821651 pooled brain, lung, testis .j 15 to 824 1 to 815   tiling clone,   815/903
(90 %)
6 diff
(99.4 %id)
TI_57199343   .j 15 to 897 70 to 960 V208C D209G E210* tiling clone,   889/972
(91 %)
25 diff
(97.5 %id)
CN356163 embryonic stem cells, cell lines H1, H7, andH9 .j 71 to 532 12 to 473       462/473
(97 %)
0 diff
(100 %id)
CN356162 embryonic stem cells, cell lines H1, H7, andH9 .k 1 to 714 1 to 714   tiling clone,   714/714
(100 %)
0 diff
(100 %id)
DA371128 thalamus .k 593 to 1155 2 to 564   tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
BM709458 eye, optic nerve .l 1 to 206 1 to 206   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 206/206
(100 %)
0 diff
(100 %id)
BU733421 eye, optic nerve .l 145 to 794 666 to 17 exact tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 650/650
(100 %)
0 diff
(100 %id)
DC337450 substantia nigra .m 1 to 565 1 to 566 V32G Q33A T34D A35C A36G ... tiling clone,   566/566
(100 %)
1 diff
(99.9 %id)
BX490631   .m 481 to 728 247 to 1   tiling clone, Submitted on the opposite strand 247/357
(69 %)
4 diff
(98.9 %id)
BP272314   .n 1 to 599 2 to 599   tiling clone,   599/599
(100 %)
7 diff
(98.9 %id)
DA426507 colon .n 3 to 583 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BU956957 adenocarcinoma, cell line, breast .n 13 to 793 1 to 787 N133H P138A N139H T140H E141R ... tiling clone,   787/916
(85 %)
18 diff
(98.1 %id)
CB111888 Liver .n 36 to 672 1 to 637       637/637
(100 %)
1 diff
(99.9 %id)
BP224649   .o 1 to 589 1 to 589 S46N tiling clone,   589/589
(100 %)
1 diff
(99.9 %id)
H50736 liver and spleen .p 1 to 480 12 to 499   tiling clone,   488/501
(97 %)
24 diff
(95.3 %id)
H50648 liver and spleen .p 884 to 1298 430 to 9   tiling clone,   422/432
(97 %)
0 diff
(100 %id)
CN356160 embryonic stem cells, cell lines H1, H7, andH9 .q 1 to 579 1 to 576 exact tiling clone,   576/576
(100 %)
6 diff
(99.0 %id)
AA642178   .r 1 to 243 1 to 243 R75Q tiling clone,   243/251
(96 %)
2 diff
(99.3 %id)
BP377938 uterus .s 1 to 582 1 to 582 V82A tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
BM313312 Pancreas, Purified pancreatic islet .s 446 to 915 17 to 486       470/486
(96 %)
6 diff
(98.8 %id)
CA775009 Pancreas, Purified pancreatic islet .s 466 to 1149 1 to 684   tiling clone, fully sequenced,   684/684
(100 %)
5 diff
(99.3 %id)
CA774758 Pancreas, Purified pancreatic islet .s 589 to 869 281 to 1   fully sequenced,   281/281
(100 %)
0 diff
(100 %id)
AA565854 adrenal adenoma, adrenal gland .s 687 to 1123 437 to 1       437/437
(100 %)
0 diff
(100 %id)
BM313035 Pancreas, Purified pancreatic islet .s 731 to 1154 424 to 1       424/424
(100 %)
1 diff
(99.8 %id)
AI690583 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .s 731 to 1150 436 to 17   AAA   420/420
(100 %)
2 diff
(99.6 %id)
AI300600 carcinoid, lung .s 797 to 1149 353 to 1       353/475
(74 %)
9 diff
(98.2 %id)
DW438494 Liver .s 1053 to 1231 17 to 196   tiling clone, AAA   180/196
(91 %)
6 diff
(97.0 %id)
CD723564 eye, lacrimal gland .s 1163 to 1791 1 to 629   tiling clone,   629/629
(100 %)
0 diff
(100 %id)
CN274326 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .t-u 1 to 698 1 to 698 exact tiling clone,   698/698
(100 %)
5 diff
(99.3 %id)
DB044147 testis .u 1 to 575 2 to 577 exact tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
DB455610 testis .va 1 to 483 1 to 483 exact tiling clone,   483/483
(100 %)
1 diff
(99.8 %id)
BF882307 lung_tumor .vb-u 1 to 193 1 to 192 exact tiling clone,   192/192
(100 %)
5 diff
(97.4 %id)
BE140480 head_neck .vb-u 90 to 356 271 to 5 exact tiling clone, Submitted on the opposite strand 267/278
(96 %)
0 diff
(100 %id)
BF853122 lung_normal .vc-u 1 to 133 8 to 139 I2S S3P I4S W5D S6Y ... tiling clone,   137/139
(98 %)
6 diff
(95.7 %id)
BQ232520 melanotic melanoma, skin Gene DNPEP, variant not shown         This clone was ignored    
176 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t-u, .u, .va, .vb-u, .vc-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI